Prev Arrow Stocks

Tilray Inc. ($TLRY) Stock Forecast: Up 5.8% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Tilray Inc.?

Tilray Brands Inc. (TLRY) is a global consumer packaged goods company specializing in cannabis, beverage, and wellness industries. Today, the stock had a strong bullish movement in the market.

Why is Tilray Inc. going up?

TLRY stock is up 5.8% on Aug 28, 2025 18:25

  • Expanded its German medical marijuana lineup with three EU-GMP strains, boosting investor confidence in its growth prospects.
  • Successfully regained compliance with Nasdaq's minimum bid price requirement, alleviating concerns about its listing status.
  • Overall cannabis sector experienced a rally driven by optimism for U.S. cannabis reform, lifting Tilray's stock along with other industry peers.
  • The positive news and market sentiment surrounding Tilray contributed to the bullish movement in its stock price today.

TLRY Price Chart

TLRY Technical Analysis

TLRY News

What's Going On With Tilray Stock Today? - Cronos Group ( NASDAQ:CRON ) , Canopy Growth ( NASDAQ:CGC )

Tilray expands German medical marijuana lineup with three EU-GMP strains rolling out Sept-early Oct. Get Discounted Real-Time Trade Alerts For a Volatile Market ( Labor Day Special ) Tilray Brands, Inc.

https://www.benzinga.com/cannabis/25/08/47392732/whats-going-on-with-tilray-stock-today-2

0 News Article Image What's Going On With Tilray Stock Today? - Cronos Group  ( NASDAQ:CRON ) , Canopy Growth  ( NASDAQ:CGC )

Tilray Brands Successfully Regains Compliance with Nasdaq's Minimum Bid Price Requirement

NEW YORK and LEAMINGTON, Ontario, Aug. 27, 2025 ( GLOBE NEWSWIRE ) -- Tilray Brands, Inc. ( "Tilray" or the "Company" ) ( Nasdaq: TLRY. TSX: TLRY ) , a global consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today announced that it received ...

https://www.globenewswire.com/news-release/2025/08/27/3140436/0/en/Tilray-Brands-Successfully-Regains-Compliance-with-Nasdaq-s-Minimum-Bid-Price-Requirement.html

1 News Article Image Tilray Brands Successfully Regains Compliance with Nasdaq's Minimum Bid Price Requirement

What's Going On With Tilray Brands ( TLRY ) Stock? - Tilray Brands ( NASDAQ:TLRY )

Shares of Tilray Brands are trading higher Tuesday. The cannabis sector is experiencing a broad rally fueled by growing optimism for U.S. cannabis reform. See the seasonal trading strategy that's beating the S&P 500 by 6X this year. Details here →

https://www.benzinga.com/trading-ideas/movers/25/08/47338770/whats-going-on-with-tilray-brands-tlry-stock

2 News Article Image What's Going On With Tilray Brands  ( TLRY )  Stock? - Tilray Brands  ( NASDAQ:TLRY )

Tilray Inc. Price History

26.07.2025 - TLRY Stock was up 5.6%

  • TLRY stock surged as the cannabis sector rallied, driven by increasing optimism for U.S. cannabis reform.
  • Growing expectations for favorable regulatory changes in the U.S. cannabis market likely boosted investor sentiment towards TLRY.
  • The positive market movement could also be attributed to a seasonal trading strategy outperforming the S&P 500, attracting more investors to cannabis stocks like TLRY.
  • Overall, the bullish trend in TLRY reflects the sector's positive outlook and investor confidence in potential regulatory developments.

24.06.2025 - TLRY Stock was down 5.4%

  • TLRY's stock saw a significant decline today, closing at $0.74, reflecting a -6.34% decrease compared to the previous day.
  • The downward trend in the market may be linked to investor reactions concerning the possibly underwhelming Q4 earnings projections for Tilray Brands. Analysts are delving into estimations beyond financial figures such as revenue and EPS.
  • While the overall market showed an increase, Tilray Brands, Inc. did not benefit from the positive movement, which could signal investor apprehensions regarding the company's current performance and future outlook.

29.06.2025 - TLRY Stock was down 11.3%

  • TLRY surpassed EPS estimates but fell short of revenue projections in its Q4 earnings report, resulting in a mixed investor response.
  • The stock's decline could be linked to disappointment over missing revenue targets, despite exceeding expectations for earnings per share.
  • Concerns about TLRY's future growth prospects and revenue performance may have prompted investors to sell off the stock.
  • TLRY's lagging performance relative to the overall market uptrend may have led some traders to shift their attention to other income stocks that are thriving in the present market conditions.

29.06.2025 - TLRY Stock was down 14.5%

  • Despite surpassing earnings per share (EPS) estimates in Q4, Tilray's stock witnessed a downward trend due to falling short on revenue predictions.
  • Investor response indicates a higher value placed on revenue performance over the beat in EPS, signaling apprehensions regarding the company's future growth.
  • The Q4 results, which were a mix of performance, are testing Tilray's efforts to turn around, underlining the significance of meeting revenue goals to maintain market trust.
  • As Tilray's stock declines amid a bullish market, it highlights the unique obstacles the company is confronting, underscoring the necessity for a strong growth plan to reestablish investor confidence.

13.07.2025 - TLRY Stock was up 15.1%

  • Following discussions about the potential reclassification of marijuana by President Trump, TLRY stock saw a notable uptrend.
  • The partnership between FL Group and Molteni aimed at broadening access to medical cannabis in Italy was another factor contributing to the positive market sentiment towards Tilray, hinting at growth prospects in overseas markets.
  • With an increase in education among physicians in pain and dependency management, Tilray's credibility and market position are likely to improve, instilling confidence among investors in the company's stock.

23.06.2025 - TLRY Stock was down 5.2%

  • Despite outperforming the market in the previous trading session, Tilray Brands (TLRY) saw a notable decline in stock value today.
  • Analysts believe that TLRY's Q4 earnings might have not met expectations, resulting in a pessimistic market sentiment.
  • The contrast between the recent positive movement and today's bearish trend suggests a possible change in investor sentiment or challenges in the cannabis sector.
  • Investors seem wary of TLRY's key metrics performance, potentially contributing to the substantial drop in stock price.

18.07.2025 - TLRY Stock was up 6.0%

  • Tilray's stock surged by 14.13% after hours following information about President Trump considering reclassifying marijuana, indicating potential positive implications for the industry.
  • The company's request for more time from Nasdaq to meet listing standards and forming new partnerships in Italy to expand medical cannabis access have likely generated investor optimism.
  • Partnerships with FL Group and Molteni to boost medical cannabis access and physician education in Italy could be seen as strategic moves, contributing to the bullish sentiment surrounding Tilray.
  • Overall, the combination of positive industry information and strategic partnerships has likely fueled the strong bullish movement in Tilray's stock today.

28.07.2025 - TLRY Stock was up 5.8%

  • Expanded its German medical marijuana lineup with three EU-GMP strains, boosting investor confidence in its growth prospects.
  • Successfully regained compliance with Nasdaq's minimum bid price requirement, alleviating concerns about its listing status.
  • Overall cannabis sector experienced a rally driven by optimism for U.S. cannabis reform, lifting Tilray's stock along with other industry peers.
  • The positive news and market sentiment surrounding Tilray contributed to the bullish movement in its stock price today.

28.07.2025 - TLRY Stock was up 6.3%

  • Regained compliance with Nasdaq's minimum bid price requirement, which boosted investor confidence in TLRY's financial stability.
  • The overall bullish movement in the cannabis sector, supported by growing optimism for U.S. cannabis reform, led to a surge in Tilray's stock price.
  • The company's adherence to regulations and positive sector sentiment likely drove TLRY's significant upward movement recently.

18.06.2025 - TLRY Stock was up 6.1%

  • Today's positive momentum in TLRY may be linked to:
  • Favorable company disclosures and advancements sparking investor confidence.
  • Growing trading activity signaling increased interest and belief in the stock.
  • Favorable market conditions and industry trends supporting cannabis-related stocks.
  • Recent updates from the company could have prompted a favorable response from investors, leading to a rise in the stock value.
  • The optimistic trend might also be influenced by general market mood and cannabis sector-specific information impacting companies like Tilray.

12.07.2025 - TLRY Stock was up 44.4%

  • TLRY stock jumped by 14.13% after hours due to speculation about potential reclassification of marijuana by the government, signaling a promising future for the industry.
  • Investors reacted optimistically to the news of marijuana possibly being reclassified, leading to a surge in Tilray's stock price.
  • This development highlights the considerable impact that regulatory decisions can have on the performance of cannabis companies like Tilray.
  • The bullish movement in TLRY demonstrates the market's responsiveness to regulatory changes that could affect the cannabis sector.

14.07.2025 - TLRY Stock was down 5.2%

  • Tilray's application for an extension from Nasdaq to meet listing requirements might have sparked worries among investors regarding the company's adherence to standards and financial stability, resulting in a bearish atmosphere.
  • While the collaboration with FL Group and Molteni to enhance medical cannabis availability in Italy was viewed positively, it may not have fully counteracted the broader market dynamics impacting the stock's descent.
  • Although Tilray exhibited a surge in post-market trading post reports of potential cannabis reclassification by President Trump, the general market sentiment during regular trading hours may have been swayed by various other factors, contributing to the downtrend.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.